Intech Investment Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Intech Investment Management LLC

  • $10 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Oct 18, 2024
SELL
$37.14 - $64.82 $221,540 - $386,651
-5,965 Reduced 28.0%
15,342 $918,000
Q4 2023

Feb 09, 2024
SELL
$37.14 - $64.82 $221,540 - $386,651
-5,965 Reduced 28.0%
15,342 $918,000
Q3 2023

Oct 18, 2024
BUY
$23.65 - $89.22 $503,910 - $1.9 Million
21,307 New
21,307 $810,000
Q3 2023

Nov 13, 2023
BUY
$23.65 - $89.22 $503,910 - $1.9 Million
21,307 New
21,307 $810,000

Others Institutions Holding APLS

# of Institutions
299
Shares Held
111M
Call Options Held
2.63M
Put Options Held
845K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email